| Filed On | Filing |
|---|---|
| 08 May 2024 |
8-K/A: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 14 May 2020 |
8-K/A: Completion of Acquisition or Disposition of Assets
The following unaudited pro forma condensed combined financial information gives effect to the acquisition of Allergan plc ("Allergan") by Venice Subsidiary LLC ("Acquirer Sub"), a direct wholly-owned subsidiary of AbbVie Inc. ("AbbVie")... |
| 06 May 2016 |
8-K/A: Entry into a Material Definitive Agreement
treatment request. This text has been seperately filed with the SEC. |
| 07 Aug 2015 |
8-K/A: Financial Statements and Exhibits
The following unaudited pro forma condensed combined statement of earnings for the six months ended June 30, 2015 has been prepared to illustrate the estimated effects of: (i) the acquisition of Pharmacyclics, Inc. (Pharmacyclics) by Abb... |
| 19 Mar 2013 |
8-K/A: Changes in Registrant's Certifying Accountant
Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 |
Loading...